When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
AZRX - AzurRx BioPharma launches European arm of cystic fibrosis study
AzurRx BioPharma Inc.
AzurRx BioPharma (AZRX) announces that nine of the expected 15 clinical trial sites in the European arm of its Phase 2b OPTION 2 study are active and recruiting participants. The trial is evaluating MS1819 in 30 cystic fibrosis patients with exocrine pancreatic insufficiency.
More news on: AzurRx BioPharma, Inc., Healthcare stocks news,